Cytokinetics Releases Inaugural Corporate Responsibility Report
“At Cytokinetics, being a responsible corporate citizen is a natural extension of our company values, and in order for us to be successful, our goals must be aligned to the well-being of our employees and the communities that we serve and in which we operate,” said
Cytokinetics’ inaugural report focuses on Empowering Lives in the communities it serves and highlights three strategic pillars as a framework for reporting. These pillars are:
- Keeping patients at the center of our work
- Advancing a high-integrity, diverse and inclusive culture
- Supporting sustainable communities
The release of Cytokinetics’ inaugural Corporate Responsibility Report is part of its ongoing commitment to providing transparency and accountability on matters related to corporate responsibility. The Company intends to release an annual update to report on progress toward its goals and to ensure that all stakeholders are kept informed. For more information, please visit: www.cytokinetics.com/responsibility.
This press release and our Corporate Responsibility Report contain forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the “Act”). Cytokinetics disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act’s Safe Harbor for forward-looking statements. Examples of such statements, express or implied, relating to Cytokinetics’ ability to obtain regulatory approval for any of its drug candidates in any indication or its research and development activities, Cytokinetics’ ability to ensure or improve access to treatment using any of its drug candidates, or Cytokinetics’ ability to reduce its greenhouse gas emissions. Such statements are based on management’s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to the risks related to Cytokinetics’ business outlines in Cytokinetics’ filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and Cytokinetics’ actual results of operations, financial condition and liquidity, and the development of the industry in which it operates, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that Cytokinetics makes in this press release speak only as of the date of this press release. Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.
CYTOKINETICS® and the
Senior Vice President, Corporate Communications, Investor Relations
Source: Cytokinetics, Incorporated